Global Animal Therapeutics and Diagnostics Market Expected to Reach $36,226 Million by 2022 - Allied Market Research
PORTLAND, Oregon and PUNE, India, March 17, 2017 /PRNewswire/ --
Global Animal Diagnostics and Therapeutics Market published by Allied Market Research, forecasts that the global market was valued at $23,793 million in 2015 and is projected to reach $36,226 million by 2022, registering a CAGR of 6.1% during the forecast period, 2016 - 2022.
(Logo: http://photos.prnewswire.com/prnh/20140911/647229 )
Animal diagnostics is essential to ensure better understanding of the cause of any ailment. Animal diagnostics consists of various instruments and consumables, which can assist in the diagnosis of diseases, whereas therapeutic agents are useful in the treatment of diseases via their mode of action. Animal diagnostics involves determination of the factors responsible for the onset of any disease and transmission of the same. This determination is done by diagnostic instruments and consumables. Therapeutic products used in the treatment of animals comprise of different drugs that help cure the disease through their mode of action.
Summary of the Animal Diagnostics and Therapeutics Market can be accessed on the website at: https://www.alliedmarketresearch.com/animal-therapeutics-diagnostics-market
Increase in number of animal population in the developing countries, rise in demand for animal-based foods, and the rise in adoption of companion animals is the major factor that fuels the growth of this market. The animal therapeutics and diagnostics market has experienced moderate growth in the recent years due to emerging diseases affecting livestock. The outbreak of epidemics results in severe mass wipeouts of animals and is a growing concern for the industries dependent on products obtained through farm animals. Moreover, zoonotic diseases affecting animals pose a threat to the public health making diagnosis and therapeutic products an important component in disease management.
Animal therapeutics segment is anticipated to dominate the market with maximum share, in 2015 in terms of revenue. Therapeutic products are used for the treatment of various animal diseases. The treatment of diseases that affect commercial animals such as poultry and cattle is even more important, as their products in the form of milk and meat can be consumed by humans, which can lead to foodborne diseases in case of infected animals.
Companion animals is expected to be the fastest growing segment throughout the analysis period and accounts for almost one-thirds of the total share of the market in 2015. This is due to the increase in adoption rate of these animals, presence of strong bond between the owner and their companion animals, and high disposable income of the owners.
According to Hemali Narkhede, Research Manager, Healthcare at Allied Market Research, "The growth in the adoption rate of companion animals, increase in prevalence of animal diseases, and rise in the demand for meat and milk by consumers has led to an increase in demand for diagnostic and therapeutic products worldwide."
Key findings of the study
- Consumables is projected to be the fastest growing segment during the analysis period.
- Anti-parasitic drugs generated the highest revenue and is expected to continue its dominance throughout the forecast period.
- North America dominated the global animal therapeutics and diagnostics market and is projected to grow at a CAGR of 5.4%.
- Consumable animals segment occupied nearly one-third of the total market in 2015.
- China is the fastest growing country in the Asia-Pacific region, registering a CAGR of 7.8% from 2016 to 2022.
In 2015, North America displayed maximum contribution in the animal diagnostics segment accounting for one-third of the total revenue generated that year. North America also was the highest contributor in the growth of the market for therapeutics in 2015. Asia-Pacific region observes fast paced growth in both animal diagnostics and animal therapeutics market registering a CAGR of 7.8% and 6.6%, respectively. Rise in disposable income, increase in animal healthcare expenditure, and increase in trend of adopting companion animals boost the growth of the animal therapeutics and diagnostics market in the Asia-Pacific region.
The major companies profiled in the report provide extensive competitive analysis and profiles of key market players including Bayer AG, Eli Lilly and Company, Boehringer Ingelheim GmbH, Merck & Co., Inc., Zoetis Inc., Ceva Santé Animale, Sanofi S.A., Nutreco N.V., and Virbac S.A.
Read similar market research reports on Diagnostics and Biotech at: https://www.alliedmarketresearch.com/life-sciences/diagnostic-and-biotech-market-report
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact: Rahul Thakur 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Direct: +1-503-894-6022 Toll Free: +1 (800) 792-5285 (U.S. & Canada) Fax: +1 (855) 550-5975 E-mail: email@example.com
SOURCE Allied Market Research